Human medicines European public assessment report (EPAR): Osqay, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Teduglutide Viatris, teduglutide, Status: Opinion
Human medicines European public assessment report (EPAR): VacPertagen, pertussis vaccine (recombinant, acellular, component, adsorbed), Status: Opinion
Human medicines European public assessment report (EPAR): Waskyra, autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human Wiskott-Aldrich syndrome protein, Status: Opinion
Summary of opinion: Minjuvi, 13/11/2025 Positive
Human medicines European public assessment report (EPAR): Inluriyo, imlunestrant, Status: Opinion
Summary of opinion: Veyvondi, 13/11/2025 Positive
Summary of opinion: Koselugo, 13/11/2025 Positive
First gene therapy to treat rare disease Wiskott-Aldrich syndrome
Human medicines European public assessment report (EPAR): Rezurock, Belumosudil, Status: Opinion